Dasatinib versus imatinib in paediatric ALL

Affiliations

Comment

David Killock. Nat Rev Clin Oncol. 2020 Apr.

. 2020 Apr;17(4):197.

doi: 10.1038/s41571-020-0337-7.

No abstract available

Comment on

Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Shen S, Chen X, Cai J, Yu J, Gao J, Hu S, Zhai X, Liang C, Ju X, Jiang H, Jin R, Wu X, Wang N, Tian X, Pan K, Jiang H, Sun L, Fang Y, Li CK, Hu Q, Yang M, Zhu Y, Zhang H, Li C, Pei D, Jeha S, Yang JJ, Cheng C, Tang J, Zhu X, Pui CH. Shen S, et al. JAMA Oncol. 2020 Mar 1;6(3):358-366. doi: 10.1001/jamaoncol.2019.5868. JAMA Oncol. 2020. PMID: 31944221 Free PMC article. Clinical Trial.

1. Shen, S. et al. Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia — a randomized clinical trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2019.5868 (2020) - DOI - PubMed